News & media

Here you can find our news and media resources. To comply with applicable regulation in Denmark, press releases and company announcements concerning specific medicinal products or investigational candidates in late-stage development are removed from our website within three weeks of publication. Please contact us to request a copy.

  • COMPANY ANNOUNCEMENT

    Zealand Pharma major shareholder announcement: J O Hambro Capital Management

  • COMPANY ANNOUNCEMENT

    Zealand Pharma major shareholder announcement: J O Hambro Capital Management

  • COMPANY ANNOUNCEMENT

    Zealand Pharma completes registration of capital increase

  • COMPANY ANNOUNCEMENT

    Zealand Pharma major shareholder announcement: Avoro Capital Advisors LLC

  • COMPANY ANNOUNCEMENT

    Zealand Pharma announces directed issue and private placement for gross proceeds of DKK 1.45 billion

  • PRESS RELEASE

    Zealand Pharma to participate in the Goldman Sachs Healthcare C-Suite Unscripted Conference on January 4th

  • COMPANY ANNOUNCEMENT

    Total number of shares and voting rights in Zealand Pharma at December 29, 2023

  • COMPANY ANNOUNCEMENT

    U.S. Food and Drug Administration issues Complete Response Letter for dasiglucagon in congenital hyperinsulinism for up to three weeks of dosing due to inspection findings at third-party manufacturing facility

  • PRESS RELEASE

    Zealand Pharma enters into EUR 90 million finance agreement with the European Investment Bank

  • COMPANY ANNOUNCEMENT

    Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

  • COMPANY ANNOUNCEMENT

    Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

  • PRESS RELEASE

    Zealand Pharma to highlight obesity pipeline at R&D Event on December 5

Corporate management

  • Adam ALR0640

    Adam Steensberg - President and Chief Executive Officer

  • Zealand Pharma 0285 FIN

    Adam Steensberg - President and Chief Executive Officer

  • Christina ALR0693 V2

    Christina Sonnenborg Bredal - Executive Vice President and Chief People Officer

  • David ALR1003

    David Kendall - Executive Vice President, Research & Development and Chief Medical Officer

  • Henriette ALR0758

    Henriette Wennicke - Executive Vice President and Chief Financial Officer

  • Ivan ALR0873

    Ivan Møller - Executive Vice President and Chief Operating Officer

  • Ravinder ALR0732

    Ravinder Chahil - Executive Vice President and General Counsel

Research and development

Logos and icons

Zealand Pharma 1503

Stay up-to-date with the latest news from Zealand

Sign-up to receive press releases and company announcements directly to your inbox

Subscribe to news

Investor and Media contacts

  • Anna ALR0858

    Anna Krassowska

    Vice President, Investor Relations & Corporate Communications

    Email Anna